Significance of DNMT3b in oral cancer

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Chen, Wen Cheng ^a,b   Chen, Miao Fen ^a,b   Lin, Paul Yang ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE 3B; INTERLEUKIN 6; DNA (CYTOSINE 5) METHYLTRANSFERASE; IL6 PROTEIN, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MOLECULAR PATHOLOGY; MOUSE; MOUTH CANCER; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR INVASION; AGED; ANIMAL; CANCER TRANSPLANTATION; EPITHELIUM; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MIDDLE AGED; MOUTH NEOPLASMS; NUDE MOUSE; PROGNOSIS; TUMOR CELL LINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CELL LINE, TUMOR; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; EPITHELIAL-MESENCHYMAL TRANSITION; EPITHELIUM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; MALE; MICE; MICE, NUDE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PROGNOSIS;

EID: 84897979310     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089956     Document Type: Article

References (33)

1. Argiris A, Karamouzis MV, Raben D, Ferris RL (2008) Head and neck cancer. Lancet 371: 1695-1709. (Pubitemid 351671886)
2. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefebvre JL, et al. (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350: 1945-1952. (Pubitemid 38580197)
3. Hashibe M, Brennan P, Chuang SC, Boccia S, Castellsague X, et al. (2009) Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 18: 541-550.
4. Choi S, Myers JN (2008) Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res 87: 14-32.
5. Herman JG, Baylin SB (2003) Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349: 2042-2054. (Pubitemid 37448928)
6. Robertson KD (2002) DNA methylation and chromatin - unraveling the tangled web. Oncogene 21: 5361-5379.
7. Diez-Perez R, Campo-Trapero J, Cano-Sanchez J, Lopez-Duran M, Gonzalez-Moles MA, et al. (2011) Methylation in oral cancer and pre-cancerous lesions (Review). Oncol Rep 25: 1203-1209.
8. Kato K, Hara A, Kuno T, Mori H, Yamashita T, et al. (2006) Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinomas and the surrounding normal mucosa. J Cancer Res Clin Oncol 132: 735-743. (Pubitemid 44337934)
9. Roth MJ, Abnet CC, Hu N, Wang QH, Wei WQ, et al. (2006) p16, MGMT, RARbeta2, CLDN3, CRBP and MT1G gene methylation in esophageal squamous cell carcinoma and its precursor lesions. Oncol Rep 15: 1591-1597.
10. Takeshima M, Saitoh M, Kusano K, Nagayasu H, Kurashige Y, et al. (2008) High frequency of hypermethylation of p14, p15 and p16 in oral pre-cancerous lesions associated with betel-quid chewing in Sri Lanka. J Oral Pathol Med 37: 475-479.
11. Shaw R (2006) The epigenetics of oral cancer. Int J Oral Maxillofac Surg 35: 101-108.
12. Viet CT, Jordan RC, Schmidt BL (2007) DNA promoter hypermethylation in saliva for the early diagnosis of oral cancer. J Calif Dent Assoc 35: 844-849.
13. Robert MF, Morin S, Beaulieu N, Gauthier F, Chute IC, et al. (2003) DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat Genet 33: 61-65. (Pubitemid 36068683)
14. Hino R, Uozaki H, Murakami N, Ushiku T, Shinozaki A, et al. (2009) Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. Cancer Res 69: 2766-2774.
15. Daniel FI, Cherubini K, Yurgel LS, de Figueiredo MA, Salum FG (2011) The role of epigenetic transcription repression and DNA methyltransferases in cancer. Cancer 117: 677-687.
16. Su X, Lv C, Qiao F, Qiu X, Huang W, et al. (2010) Expression pattern and clinical significance of DNA methyltransferase 3B variants in gastric carcinoma. Oncol Rep 23: 819-826.
17. Kim H, Kwon YM, Kim JS, Han J, Shim YM, et al. (2006) Elevated mRNA levels of DNA methyltransferase-1 as an independent prognostic factor in primary nonsmall cell lung cancer. Cancer 107: 1042-1049. (Pubitemid 44291153)
18. Chen MF, Chen PT, Lu MS, Lin PY, Chen WC, et al. (2013) IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus. Mol Cancer 12: 26.
19. Chen MF, Wang WH, Lin PY, Lee KD, Chen WC (2012) Significance of the TGF-beta1/IL-6 axis in oral cancer. Clin Sci (Lond) 122: 459-472.
20. Gasche JA, Hoffmann J, Boland CR, Goel A (2011) Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells. Int J Cancer 129: 1053-1063.
21. Thiery JP (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454.
22. Gotzmann J, Mikula M, Eger A, Schulte-Hermann R, Foisner R, et al. (2004) Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. Mutat Res 566: 9-20. (Pubitemid 38045586)
23. Sharma S, Sharma MC, Sarkar C (2005) Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis. Histopathology 46: 481-489. (Pubitemid 40632304)
24. Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, et al. (1999) The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res 27: 2291-2298. (Pubitemid 29245646)
25. Lin RK, Hsu HS, Chang JW, Chen CY, Chen JT, et al. (2007) Alteration of DNA methyltransferases contributes to 5′CpG methylation and poor prognosis in lung cancer. Lung Cancer 55: 205-213.
26. Robertson KD (2001) DNA methylation, methyltransferases, and cancer. Oncogene 20: 3139-3155.
27. Smith A, Teknos TN, Pan Q (2013) Epithelial to mesenchymal transition in head and neck squamous cell carcinoma. Oral Oncol 49: 287-292.
28. Quan J, Johnson NW, Zhou G, Parsons PG, Boyle GM, et al. (2012) Potential molecular targets for inhibiting bone invasion by oral squamous cell carcinoma: a review of mechanisms. Cancer Metastasis Rev 31: 209-219.
29. Culig Z (2013) Interleukin-6 as a therapy target in oral squamous carcinoma. Expert Opin Ther Targets 17: 53-59.
30. Jones SA, Richards PJ, Scheller J, Rose-John S (2005) IL-6 transsignaling: the in vivo consequences. J Interferon Cytokine Res 25: 241-253. (Pubitemid 40664421)
31. Braconi C, Huang N, Patel T (2010) MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes. Hepatology 51: 881-890.
32. Foran E, Garrity-Park MM, Mureau C, Newell J, Smyrk TC, et al. (2010) Upregulation of DNA methyltransferase-mediated gene silencing, anchorage-independent growth, and migration of colon cancer cells by interleukin-6. Mol Cancer Res 8: 471-481.
33. Chen CC, Chen WC, Wang WH, Lu CH, Lin PY, et al. (2011) Role of DNA methyltransferase 1 in pharyngeal cancer related to treatment resistance. Head Neck 33: 1132-1143.